UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

Blood, 2007-12, Vol.110 (13), p.4614-4617

2007

Volltextzugriff (PDF)

Non-invasive predictors of survival in cardiac amyloidosis

European journal of heart failure, 2007-06, Vol.9 (6-7), p.617-624

2007

Volltextzugriff (PDF)

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Blood, 2005-07, Vol.106 (2), p.458-463

2005

Volltextzugriff (PDF)

Rapid Progression of Left Ventricular Wall Thickness Predicts Mortality in Cardiac Light-chain Amyloidosis

The Journal of heart and lung transplantation, 2007-12, Vol.26 (12), p.1313-1319

2007

Volltextzugriff (PDF)

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis

Haematologica (Roma), 2008-03, Vol.93 (3), p.459-462

2008

Volltextzugriff (PDF)

CD4+CD25highCD127low Regulatory T Cells in Peripheral Blood Are Not an Independent Factor for Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

TheScientificWorld, 2012-01, Vol.2012 (2012), p.1-10

2012

Volltextzugriff (PDF)

Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma

Future oncology (London, England), 2008-04, Vol.4 (2), p.169-177

2008

Volltextzugriff (PDF)

High‐dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

British journal of haematology, 2004-12, Vol.127 (5), p.543-551

2004

Volltextzugriff (PDF)

Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation

Haematologica (Roma), 2009-04, Vol.94 (4), p.594-596

2009

Volltextzugriff (PDF)

Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with Imatinib

International journal of cardiology, 2011-09, Vol.151 (3), p.e90-e92

2011

Volltextzugriff (PDF)

Risk stratification in cardiac amyloidosis: novel approaches

Transplantation, 2005-09, Vol.80 (1 Suppl), p.S151-S155

2005

Volltextzugriff (PDF)

Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia

Haematologica (Roma), 2006-08, Vol.91 (8), p.1145-1146

2006

Volltextzugriff (PDF)

Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation

Leukemia research, 2007-10, Vol.31 (10), p.1433-1436

2007

Volltextzugriff (PDF)

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis

Transplantation, 2005-09, Vol.80 (1 Suppl), p.S160-S163

2005

Volltextzugriff (PDF)

Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab

Transplant immunology, 2007-11, Vol.18 (2), p.179-185

2007

Volltextzugriff (PDF)

Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation

Clinical research in cardiology, 2006-12, Vol.95 (12), p.671-674

2006

Volltextzugriff (PDF)

Prospective Phase II Study Using Dexamethasone Induction Therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation in 30 Patients with Systemic AL Amyloidosis

Blood, 2009-11, Vol.114 (22), p.3401-3401

2009

Volltextzugriff (PDF)

Fall 2463

Deutsche medizinische Wochenschrift, 1999-02, Vol.124 (8), p.217-218

1999

Volltextzugriff (PDF)

No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement

Nephrology, dialysis, transplantation, 2003-12, Vol.18 (12), p.2644-2647

2003

Volltextzugriff (PDF)

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib

Blood, 2004-02, Vol.103 (4), p.1495-1498

2004

Volltextzugriff (PDF)

Long Term Survival Analysis after High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation for Treatment of AL Amyloidosis: A Single Centre Experience

Blood, 2005-11, Vol.106 (11), p.5503-5503

2005

Volltextzugriff (PDF)

Long-Term Outcome after LACE (Lomustine, Ara-C, Cyclophosphamide, Etoposide) Conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: A Single Centre Experience

Blood, 2005-11, Vol.106 (11), p.5502-5502

2005

Volltextzugriff (PDF)

Impact of HLA Class I and Class II DNA High-Resolution HLA Typing on Outcome in Adult Unrelated Stem Cell Transplantation after In Vivo T-Cell Depletion with CAMPATH 1H: A Single Centre Experience in 100 Patients

Blood, 2005-11, Vol.106 (11), p.1804-1804

2005

Volltextzugriff (PDF)

Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen: Herausgegeben von der Deutschen Gesellschaft für Amyloid-Krankheiten e. V. (www.amyloid.de)

Medizinische Klinik (München. 1983), 2006-10, Vol.101 (10), p.825-829

2006

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(22)
Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Adult
(17)
Male
(16)
Female
(14)
Middle Aged
(14)
Hematology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Aged
(9)
Hematologic And Hematopoietic Diseases
(7)
Stem Cell Transplantation
(7)
Transplantation
(7)
Treatment Outcome
(7)
Amyloidosis - Therapy
(6)
Antineoplastic Agents - Therapeutic Use
(6)
Benzamides
(6)
Imatinib Mesylate
(6)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia

Non-invasive predictors of survival in cardiac amyloidosis

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

Rapid Progression of Left Ventricular Wall Thickness Predicts Mortality in Cardiac Light-chain Amyloidosis

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis

CD4+CD25highCD127low Regulatory T Cells in Peripheral Blood Are Not an Independent Factor for Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma

High‐dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study

Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation

Complete reversal of left ventricular mass in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia after therapy with Imatinib

Risk stratification in cardiac amyloidosis: novel approaches

Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia

Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis

Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab

Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation

Prospective Phase II Study Using Dexamethasone Induction Therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation in 30 Patients with Systemic AL Amyloidosis

Fall 2463

No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib

Long Term Survival Analysis after High-Dose Melphalan Chemotherapy Followed by Autologous Stem Cell Transplantation for Treatment of AL Amyloidosis: A Single Centre Experience

Long-Term Outcome after LACE (Lomustine, Ara-C, Cyclophosphamide, Etoposide) Conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: A Single Centre Experience

Impact of HLA Class I and Class II DNA High-Resolution HLA Typing on Outcome in Adult Unrelated Stem Cell Transplantation after In Vivo T-Cell Depletion with CAMPATH 1H: A Single Centre Experience in 100 Patients

Interdisziplinäre Leitlinien zur Diagnostik und Therapie der extrazerebralen Amyloidosen: Herausgegeben von der Deutschen Gesellschaft für Amyloid-Krankheiten e. V. (www.amyloid.de)

Suchergebnisse filtern